Cost-Effectiveness Analysis of Docetaxel Versus Weekly Paclitaxel in Adjuvant Treatment of Regional Breast Cancer in New Zealand
Crossref DOI link: https://doi.org/10.1007/s40273-014-0154-x
Published Online: 2014-05-24
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Webber-Foster, Rachel
Kvizhinadze, Giorgi
Rivalland, Gareth
Blakely, Tony
Text and Data Mining valid from 2014-05-24